TherapeuticsMD (TXMD) Cost of Revenue (2011 - 2023)
TherapeuticsMD (TXMD) recorded Cost of Revenue of $106,000 in Q3 2023, down 70.1% from $354,000 a year earlier.
Powered by 
Analysis
TherapeuticsMD (TXMD) Cost of Revenue (2011 - 2023) Analysis & Trends
For FY2022, TherapeuticsMD reported Cost of Revenue of $1.4 million, down 0.4% from FY2021.
- Annual Cost of Revenue has a five-year compound annual growth rate of -11.9% (FY2017 to FY2022).
- Across earlier years, Cost of Revenue came in at $1.4 million in FY2021 (-91.2%), $15.98 million in FY2020 (+152.2%), $6.34 million in FY2019 (+131.4%) and $2.74 million in FY2018 (+3.8%).
- The Q3 2023 figure is the lowest quarterly Cost of Revenue since Q4 2021.
- Peak year-over-year performance for Cost of Revenue in the last five years was growth of 255.9% in Q1 2020, against a decline of 93.3% in Q3 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | TherapeuticsMD | 20.83 Mn | 20.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 106,000.00 |
| Sep 30, 2022 | 354,000.00 |
| Jun 30, 2022 | 348,000.00 |
| Mar 31, 2022 | 695,000.00 |
| Dec 31, 2021 | -12.70 Mn |
| Sep 30, 2021 | 5.28 Mn |
| Jun 30, 2021 | 4.13 Mn |
| Mar 31, 2021 | 4.69 Mn |
| Dec 31, 2020 | 5.58 Mn |
| Sep 30, 2020 | 3.28 Mn |
| Jun 30, 2020 | 4.40 Mn |
| Mar 31, 2020 | 2.72 Mn |
| Dec 31, 2019 | 2.88 Mn |
| Sep 30, 2019 | 1.44 Mn |
| Jun 30, 2019 | 1.25 Mn |
| Mar 31, 2019 | 762,827.00 |
| Dec 31, 2018 | 950,750.00 |
| Sep 30, 2018 | 699,118.00 |
| Jun 30, 2018 | 454,161.00 |
| Mar 31, 2018 | 633,623.00 |
API Access
TherapeuticsMD Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();